Guidelines for Managing Lung Tuberculosis, Tuberculosis Outside the Lungs, and Special Tuberculosis Cases
Updated
Abstract
The prevalence of TB and HIV co-infection worldwide is 0.18%, with about 8% of TB cases also having HIV infection.
- Effective chemotherapy for TB has been available for over 50 years, yet multidrug-resistant TB (MDR TB) remains a significant concern.
- The incidence of MDR TB in Delhi was found to be 14%, primarily acquired due to inadequate chemotherapy.
- Sputum smear examination is recommended as the preferred screening method, with positivity rates exceeding 90% when more than 5 ml of sputum is analyzed.
- Culture methods for diagnosing TB are significantly more sensitive than smear tests, detecting as few as 10-100 viable bacteria per ml.
- Isoniazid and rifampicin resistance can be reliably measured, while resistance to other drugs like pyrazinamide is more challenging.
- Treatment of TB in patients with HIV co-infection is effective, but relapse rates may be higher and complications can arise after initiating therapy.
Simplified